SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-16
👔
Traws Pharma, Inc.
@TRAW_InsiderForm 4 Filing: Pauza Charles David Acquires (Grant) shares of $TRAW
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Traws Pharma, Inc.
Ticker: $TRAW
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 97,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pauza Charles David, holds the title of Chief Science Officer Virology at Traws Pharma, Inc..
On 2026-07-09, the insider transacted 97,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Pauza Charles David (Chief Science Officer Virology) was granted $0 of $TRAW
Post-Transaction Position: 97,000 shares
SEC Accession No: 0002018150-26-000003 (CIK: 2018150)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.